Aspyrian Therapeutics, Inc., is a privately funded clinical stage biotechnology company developing a new class of precision targeted oncologic drugs for the treatment of solid tumors based on a new proprietary cancer targeted platform, Photoimmunotherapy. The Company's first product, RM-1929, is in clinical phase 1 testing to treat recurrent Head and Neck Cancer patients.
View Top Employees from Aspyrian Therapeutics, Inc| Website | http://www.rakuten-med.com |
| Revenue | $16 million |
| Funding | $233 million |
| Employees | 160 (160 on RocketReach) |
| Founded | 2010 |
| Phone | (858) 925-5619 |
| Industry | Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Cancer Therapeutics, Healthcare, Antibody Conjugates, Immunooncology |
| Competitors | Aura Biosciences, Juno Therapeutics, Inc., Perthera AI, Takeda China, bluebird bio |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Aspyrian Therapeutics, Inc employee's phone or email?
Aspyrian Therapeutics, Inc Questions
The Aspyrian Therapeutics, Inc annual revenue was $16 million in 2023.
Suzane San is the Chief People Officer of Aspyrian Therapeutics, Inc.
160 people are employed at Aspyrian Therapeutics, Inc.
Aspyrian Therapeutics, Inc is based in San Diego, California.
The NAICS codes for Aspyrian Therapeutics, Inc are [32, 541, 5417, 54, 325, 32541, 3254].
The SIC codes for Aspyrian Therapeutics, Inc are [28, 283].
Top Aspyrian Therapeutics, Inc Employees
-
21
-
ViewAgatha Martindale
Vice President, Global Finance at Aspyrian Therapeutics, Inc
Del Mar, California, United States45+ -
35+
-
ViewHaiying Dong
Executive Director, Global Data and Analytics at Aspyrian Therapeutics, Inc
San Francisco, California, United States21 -
25+
Related Companies
